Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein C Concentrate in Severe Congenital Protein C Deficiency
NCT00157118Phase 3Completed
- Sponsor
- Takeda
- Start
- Aug 2003
- Primary completion
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of Protein C concentrate in protein C deficiency (3 arms), sponsored by Takeda. Primary endpoint: Efficacy of Protein C Concentrate in treating acute episodes. Started Aug 2003; status: completed.
02
Drugs
Protein C concentrate
03
Conditions
protein C deficiency
Beyond the preview
Go deeper on NCT00157118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157118.